1. Home
  2. DHI vs NTRA Comparison

DHI vs NTRA Comparison

Compare DHI & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D.R. Horton Inc.

DHI

D.R. Horton Inc.

HOLD

Current Price

$150.37

Market Cap

43.8B

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$275.19

Market Cap

39.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHI
NTRA
Founded
1978
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8B
39.1B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
DHI
NTRA
Price
$150.37
$275.19
Analyst Decision
Hold
Strong Buy
Analyst Count
14
15
Target Price
$166.08
$259.07
AVG Volume (30 Days)
2.5M
1.0M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
1.19%
N/A
EPS Growth
N/A
0.65
EPS
7.45
N/A
Revenue
$34,250,400,000.00
$210,939,000.00
Revenue This Year
$0.05
$18.08
Revenue Next Year
$5.85
$19.65
P/E Ratio
$19.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$131.75
$135.75
52 Week High
$183.62
$288.04

Technical Indicators

Market Signals
Indicator
DHI
NTRA
Relative Strength Index (RSI) 50.24 59.87
Support Level $145.45 $186.96
Resistance Level $150.06 $288.04
Average True Range (ATR) 4.65 11.17
MACD 0.10 -1.02
Stochastic Oscillator 56.52 76.42

Price Performance

Historical Comparison
DHI
NTRA

About DHI D.R. Horton Inc.

D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: